fbpx

Brain Cancer

Bifrontal Glioblastoma Multiforme

Male, 26 years

Patient Internal 708782583

ICD-10 code

C71.9 Malignant neoplasm: Brain, Unspecified

Diagnosis (Incl. Metastases/Stage) and Year

December 2014
Bifrontal Glioblastoma Multiforme Midline Glioma, WHO Grade 4, TP53 (+) and IDH1(+) Gene Mutations.

Previous Treatment

Radiation Therapy, Chemotherapy (Temozolomide), Target Therapy (Ipatasertib+Atezolizumab).

Prognosis and Survival Expectation

The prognosis remains poor, with a median survival of ~14 months from diagnosis.

Treatment Provided

Autologous DCV (3 doses) over a period of 1 month.

Patient Survival/Condition and Year
Date of Review: 01/12/2023

The patient survived for 6 years and 5 months after diagnosis. It can be concluded that Immunotherapy, alongside Radiation Therapy, Chemotherapies and Target Therapies, extended patient survival by an estimate of around 5 years.

Disclaimer

We encourage you to learn more about your condition and treatment options to make informed decisions about your healthcare. However, please keep in mind that not all information available online or in other sources is accurate or relevant to your specific situation. It’s important to rely on credible, evidence-based sources such as official medical websites, peer-reviewed publications, or information provided by professional healthcare organizations. Always discuss any information you find with your healthcare provider before making decisions, as they can help clarify details, address concerns, and ensure the information is appropriate for your unique needs.